🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Dyspepsia refers to chronic or recurrent upper gastrointestinal (GI) sympto...
Status
Recruiting
Location
KU Leuven
Start Date
2024-10-01
Trial ID
NCT06482671
Treatments Being Tested
The purpose of this study is to evaluate safety, tolerability, immunogenici...
Status
Completed
Location
CMAX Clinical Research
Start Date
2020-12-30
Trial ID
NCT05490017
This was a Phase III, Efficacy and Safety Study of Oleogel-S10 in Participa...
Status
Completed
Location
Phoenix Children's Hospital
Start Date
2017-03-29
Trial ID
NCT03068780
Treatments Being Tested
A Phase 2 Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Ascen...
Status
Completed
Location
PPD 137
Start Date
2015-06-12
Trial ID
NCT02462187
Treatments Being Tested
The purpose of this study is to assess the efficacy and safety of twice dai...
Status
Completed
Location
Cahaba Dermatology
Start Date
2018-12-20
Trial ID
NCT03745638
Treatments Being Tested
The purpose of this study is to to evaluate the safety and efficacy of ruxo...
Status
Recruiting
Location
University of Alabama At Birmingham-School of Medicine
Start Date
2025-01-24
Trial ID
NCT06548360
Treatments Being Tested
Randomized, Vehicle-controlled, Parallel Group Study of TDM-180935 in Atopi...
Status
Completed
Location
Site 5
Start Date
2024-04-13
Trial ID
NCT06363461
The purpose of this study is to evaluate the safety and tolerability of JNJ...
Status
Completed
Location
Multiple Locations
Start Date
2011-08
Trial ID
NCT01492647
The purpose of this Phase 1b study is to evaluate the safety, tolerability,...
Status
Completed
Location
PPD
Start Date
2019-05-02
Trial ID
NCT04284514
Treatments Being Tested
This is a Phase 2, multi-center, randomized, double-blind, placebo-controll...
Status
Recruiting
Location
The Center for Vulvovaginal Disorders - Washington, DC
Start Date
2026-01-02
Trial ID
NCT07257029
Treatments Being Tested